Literature DB >> 25676802

New aspects on the metabolic role of intestinal microbiota in the development of atherosclerosis.

Ioannis Drosos1, Anna Tavridou2, George Kolios1.   

Abstract

Gut microbiota remains a very interesting, yet largely unexplored ecosystem inside the human organism. The importance of this ecosystem for the physiology and the pathophysiology of the organism is being slowly unraveled. Recent studies reveal a connection between intestinal microbiota and atherosclerosis development. It seems that alterations in the function and composition of this bacterial population lead through complex mechanisms to a high risk for atherosclerosis. Although these mechanisms remain largely unknown, published studies show that microbiota can lead to atherosclerosis either by augmenting known risk factors or via other, more "direct" mechanisms. This review article summarizes the available literature regarding this matter.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Atherosclerosis; Coronary artery disease; Gut; Intestinal; Microbiota

Mesh:

Substances:

Year:  2015        PMID: 25676802     DOI: 10.1016/j.metabol.2015.01.007

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  12 in total

1.  Constipation and risk of death and cardiovascular events.

Authors:  Keiichi Sumida; Miklos Z Molnar; Praveen K Potukuchi; Fridtjof Thomas; Jun Ling Lu; Kunihiro Yamagata; Kamyar Kalantar-Zadeh; Csaba P Kovesdy
Journal:  Atherosclerosis       Date:  2018-12-23       Impact factor: 5.162

2.  Preclinical relevance of probiotics in type 2 diabetes: A systematic review.

Authors:  Anaísa Martins Marques; Mariáurea Matias Sarandy; Rômulo Dias Novaes; Reggiani Vilela Gonçalves; Mariella Bontempo Freitas
Journal:  Int J Exp Pathol       Date:  2020-07-01       Impact factor: 1.925

3.  Microbiome and metabonomics study of quercetin for the treatment of atherosclerosis.

Authors:  Dong-Ning Wu; Le Guan; Yi-Xin Jiang; Su-Hua Ma; Ya-Nan Sun; Hong-Tao Lei; Wei-Feng Yang; Qing-Feng Wang
Journal:  Cardiovasc Diagn Ther       Date:  2019-12

Review 4.  Sex differences in the intestinal microbiome: interactions with risk factors for atherosclerosis and cardiovascular disease.

Authors:  Shamon Ahmed; J David Spence
Journal:  Biol Sex Differ       Date:  2021-05-17       Impact factor: 5.027

5.  Commensal Microbe-specific Activation of B2 Cell Subsets Contributes to Atherosclerosis Development Independently of Lipid Metabolism.

Authors:  Lin Chen; Tomoaki Ishigami; Rie Nakashima-Sasaki; Tabito Kino; Hiroshi Doi; Shintaro Minegishi; Satoshi Umemura
Journal:  EBioMedicine       Date:  2016-10-20       Impact factor: 8.143

Review 6.  The Role of Gut Microbiota in Atherosclerosis and Hypertension.

Authors:  Junli Ma; Houkai Li
Journal:  Front Pharmacol       Date:  2018-09-25       Impact factor: 5.810

7.  Effect of Differences in the Microbiome of Cyp17a1-Deficient Mice on Atherosclerotic Background.

Authors:  Axel Künstner; Redouane Aherrahrou; Misa Hirose; Petra Bruse; Saleh Mohamed Ibrahim; Hauke Busch; Jeanette Erdmann; Zouhair Aherrahrou
Journal:  Cells       Date:  2021-05-23       Impact factor: 6.600

8.  Therapeutic potential of human umbilical cord mesenchymal stem cells on aortic atherosclerotic plaque in a high-fat diet rabbit model.

Authors:  Yanhong Li; Guiying Shi; Yunlin Han; Haiquan Shang; Huiwu Li; Wei Liang; Wenjie Zhao; Lin Bai; Chuan Qin
Journal:  Stem Cell Res Ther       Date:  2021-07-15       Impact factor: 6.832

Review 9.  Gut Microbiota: Critical Controller and Intervention Target in Brain Aging and Cognitive Impairment.

Authors:  Hui Li; Junjun Ni; Hong Qing
Journal:  Front Aging Neurosci       Date:  2021-06-25       Impact factor: 5.750

10.  Increased Risk of Acute Coronary Syndrome in Patients With Diverticular Disease: A Nationwide Population-Based Study.

Authors:  Jiun-Nong Lin; Cheng-Li Lin; Chih-Hui Yang; Ming-Chia Lin; Chung-Hsu Lai; Hsi-Hsun Lin; Chia-Hung Kao
Journal:  Medicine (Baltimore)       Date:  2015-11       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.